Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for BDX, sign up here.
Income Statement
Revenue
$19.5bn
Gross Profit
$8.1bn
Earning before Tax
$1.5bn
Net Income
$1.3bn
Net Income Common Shareholders
$1.2bn
EPS
4.23
Balance Sheet
Cash
$1.2bn
Debt
$16.1bn
Assets
$52.3bn
Liabilities
$26.9bn
Equity
$25.3bn
Enterprise Value
$85.2bn
Cash Flow Statement
Net Cash from Operations
$3.4bn
Net Cash from Investing
$-0.7bn
Net Cash from Financing
$-2.3bn
Net Cash Flow
$490.0m
Free Cash Flow
$2.6bn
Free Cash Flow per Share
$9.12
Metrics
Price to Equity
58.09
Price to Equity (Damodaran)
57.64
Price to Book
2.79
Net Margin
0.06
Return on Equity
0.05
Return on Sales
0.10
Get immediate access to 5-years of reference grade data for BDX for free.
Sign upBecton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Company Info
Industry
Medical Instruments & Supplies
Employees
73,000
Address
1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
Phone
201 847 6800
Website
Last Updated
2024-02-08
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.